Insider Shareholders with Direct Ownership of Nuvalent, Inc. (NUVL)
This section provides a comprehensive overview of the insiders with direct ownership of Nuvalent, Inc. (NUVL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Nuvalent, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,499 | 740,000 | 1,427,197 $112 Million | 25 |
Jun 12, 2024
Added 0.17%
|
|
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
> 10% Shareholder |
897,671 | 0 | 897,671 $70.3 Million | 1 |
Aug 02, 2021
Added 50.0%
|
|
James Richard Porter
President and CEO |
299,050 | 125,301 | 249,062 $19.5 Million | 12 |
Jan 15, 2025
Reduced 2.29%
|
|
Christopher Durant Turner
Chief Medical Officer |
90,123 | 27,576 | 62,547 $4.9 Million | 16 |
Jan 06, 2025
Reduced 3.36%
|
|
Alexandra Balcom
Chief Financial Officer |
180,750 | 119,016 | 61,734 $4.83 Million | 20 |
Jan 06, 2025
Reduced 3.4%
|
|
Henry E. Pelish
Chief Scientific Officer |
42,264 | 45,778 | 59,981 $4.7 Million | 6 |
Jan 06, 2025
Reduced 2.19%
|
|
Deborah Ann Miller
Chief Legal Officer |
202,596 | 153,510 | 49,086 $3.84 Million | 59 |
Jan 06, 2025
Reduced 3.16%
|
|
Darlene Noci
Chief Development Officer |
254,250 | 206,216 | 48,034 $3.76 Million | 73 |
Jan 06, 2025
Reduced 4.33%
|
| 3,200 | 0 | 3,200 $250,496 | 1 |
Dec 05, 2024
Added 50.0%
|
|
| 39,166 | 36,667 | 2,507 $196,247 | 13 |
Aug 23, 2024
Reduced 57.08%
|
|
| 2,499 | 0 | 2,499 $195,621 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $195,621 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $195,621 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $195,621 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $195,621 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $195,621 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 7,499 | 5,000 | 2,499 $195,621 | 3 |
Jun 12, 2024
Added 50.0%
|